Biogen Pharmachem Industries Ltd share price ... 4's Namita Thapar for calling out Rosha founders' 'exploitation' Thank you! Your transaction has been completed successfully.

I just wanted to say thank you for your piece on Senate Bill 14 and its implications for transparency. I appreciate this ...

Biogen (BIIB) stock in focus as company and partner Eisai (ESALF) face delay in the EU launch of Alzheimer's drug lecanemab.

In a report released today, David Amsellem from Piper Sandler maintained a Hold rating on Biogen (BIIB – Research Report), with a price target ...

In a report released today, Brian Abrahams from RBC Capital maintained a Buy rating on Biogen (BIIB – Research Report), with a price target of ...

The stock's fall snapped a five-day winning streak.

That’s the message Biogen chief executive Chris Viehbacher ... “I guess instead of a question, maybe just a plea: You know, we face a lot of scientific and commercial risk, but we’re now ...

Analysts' ratings for Biogen (NASDAQ:BIIB ... Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more.

Despite my own fiercely held belief in thank-you notes, I do think there are a handful of situations where traditional thank-you note etiquette can be relaxed in favor of more casual expressions of ...

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions ...

Biogen Inc. (BIIB), headquartered in Cambridge, Massachusetts, specializes in discovering, developing, manufacturing, and delivering therapies for neurological and neurodegenerative diseases ...

Biogen Inc. (NASDAQ:BIIB), a leading biopharmaceutical company specializing in neurology and rare diseases, finds itself at a critical juncture as it navigates a complex landscape of opportunities and ...